Icad Inc Stock Today
| ICAD Stock | USD 1.77 0.16 9.94% |
|
|
Icad is trading at 1.77 as of the 3rd of December 2023, a 9.94 percent up since the beginning of the trading day. The stock's lowest day price was 1.62. Icad has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Icad Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of October 2023 and ending today, the 3rd of December 2023. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 3rd of December 1986 | Category Healthcare | Classification Health Care |
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. The company has 26.35 M outstanding shares of which 596.84 K shares are currently shorted by private and institutional investors with about 3.61 trading days to cover. More on Icad Inc
Moving together with Icad Stock
| + | 0.87 | EW | Edwards Lifesciences Corp | Fiscal Quarter End 31st of December 2023 | PairCorr | |
| + | 0.83 | GH | Guardant Health | Fiscal Quarter End 31st of December 2023 | PairCorr | |
| + | 0.9 | OM | Outset MedicalInc | Fiscal Quarter End 31st of December 2023 | PairCorr |
Moving against Icad Stock
| - | 0.65 | EKSO | Ekso Bionics Holdings | Fiscal Quarter End 31st of December 2023 | PairCorr | |
| - | 0.61 | ENSG | Ensign Group | Fiscal Quarter End 31st of December 2023 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Fiscal Quarter End 31st of December 2023
Icad Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Icad's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Icad or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and Director | Kenneth Ferry | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SEC Filings | Icad Security & Exchange Commission EDGAR Reports | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Technology, Health Care Equipment & Services, Health Care (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Icad report their recommendations after researching Icad's financial statements, talking to executives and customers, or listening in on Icad's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Icad Inc. The Icad consensus assessment is calculated by taking the average forecast from all of the analysts covering Icad. Strong Buy2 Opinions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Piotroski F Score Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Icad Inc based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Icad Inc financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks. PoorDetails
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Macroaxis Advice The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Icad's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details Cautious HoldUndervalued | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Icad's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Icad's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Icad's financial leverage. It provides some insight into what part of Icad's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Icad Inc (ICAD) is traded on NASDAQ Exchange in USA. It is located in 98 Spit Brook Road, Nashua, NH, United States, 03062 and employs 108 people. Icad is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 46.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Icad's market, we take the total number of its shares issued and multiply it by Icad's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Icad Inc conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 26.35 M outstanding shares of which 596.84 K shares are currently shorted by private and institutional investors with about 3.61 trading days to cover.
Icad Inc currently holds about 27.18 M in cash with (12.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.07.
Check Icad Probability Of Bankruptcy
OwnershipIcad Inc has a total of twenty-six million three hundred fifty-two thousand seven hundred outstanding shares. 30% of Icad Inc outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Ownership Allocation
Check Icad Ownership DetailsIcad Stock Price Odds Analysis
What are Icad's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Icad jumping above the current price in 90 days from now is about 46.48%. The Icad Inc probability density function shows the probability of Icad stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.2731. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Icad will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Icad Inc is significantly underperforming NYSE Composite.
Based on a normal probability distribution, the odds of Icad to move above the current price in 90 days from now is about 46.48 (This Icad Inc probability density function shows the probability of Icad Stock to fall within a particular range of prices over 90 days) .
Icad Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Icad that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Icad's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Icad's value.| Instituion | Last Transaction | Type | Shares | Value | |
| Portolan Capital Management Llc | 2023-09-30 | Common Shares | 1.2 M | 2.6 M | |
| Vanguard Group Inc | 2023-09-30 | Common Shares | 1.1 M | 2.2 M | |
| Granahan Investment Management Llc | 2023-09-30 | Common Shares | 895.2 K | 1.9 M | |
| First Eagle Investment Management Llc | 2023-09-30 | Common Shares | 660.8 K | 1.4 M | |
| Eam Investors Llc | 2023-09-30 | Common Shares | 420.2 K | 886.7 K | |
| Blackrock Inc | 2023-09-30 | Common Shares | 348.7 K | 735.8 K | |
| Renaissance Technologies Llc | 2023-09-30 | Common Shares | 339.8 K | 717 K | |
| Greenwood Capital Associates Llc | 2023-09-30 | Common Shares | 325.3 K | 686.4 K | |
| Pura Vida Investments Llc | 2023-03-31 | Common Shares | 383.1 K | 475 K | |
| Geode Capital Management Llc | 2023-09-30 | Common Shares | 220.8 K | 466 K | |
| General American Investors Co Inc | 2023-09-30 | Common Shares | 200.4 K | 422.9 K |
Icad Historical Income Statement
Icad Inc Income Statement is one of the three primary financial statements used for reporting Icad's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Icad Inc revenue and expense. Icad Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Icad's Interest Expense is projected to decrease significantly based on the last few years of reporting. . The current year's Operating Expenses is expected to grow to about 36.6 M, whereas Consolidated Income is forecasted to decline to (14.7 M). View More FundamentalsIcad Stock Against Markets
Picking the right benchmark for Icad stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Icad stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Icad is critical whether you are bullish or bearish towards Icad Inc at a given time. Please also check how Icad's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Icad without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
| All Next | Launch Module |
Icad Corporate Directors
Icad corporate directors refer to members of an Icad board of directors. The board of directors generally takes responsibility for the Icad's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Icad's board members must vote for the resolution. The Icad board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Elliot Sussman | Independent Director | Profile | |
| Andrew Sassine | Director | Profile | |
| Somu Subramaniam | Independent Director | Profile | |
| Rakesh Patel | Director | Profile |
How to buy Icad Stock?
Before investing in Icad, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Icad. To buy Icad stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Icad. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Icad stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Icad Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Icad Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Icad Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Icad Stock please use our How to Invest in Icad guide.
Already Invested in Icad Inc?
The danger of trading Icad Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Icad is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Icad. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Icad Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Icad Inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icad Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Icad Stock analysis
When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world |
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.49) | Revenue Per Share 1 | Quarterly Revenue Growth (0.07) | Return On Assets (0.16) | Return On Equity (0.37) |
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.